PRETTA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 31.295
NA - Nord America 903
AS - Asia 378
AF - Africa 5
OC - Oceania 3
SA - Sud America 1
Totale 32.585
Nazione #
IT - Italia 30.997
US - Stati Uniti d'America 889
CN - Cina 199
SE - Svezia 126
SG - Singapore 93
DE - Germania 38
IN - India 27
NL - Olanda 27
FI - Finlandia 25
GB - Regno Unito 25
FR - Francia 14
KR - Corea 14
CA - Canada 10
IE - Irlanda 10
HK - Hong Kong 8
VN - Vietnam 8
BE - Belgio 7
IR - Iran 7
JP - Giappone 6
ES - Italia 5
AT - Austria 4
TH - Thailandia 4
TR - Turchia 4
UA - Ucraina 4
AU - Australia 3
BZ - Belize 3
GR - Grecia 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
IL - Israele 2
MU - Mauritius 2
PT - Portogallo 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BR - Brasile 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 32.585
Città #
Cagliari 28.998
Uta 1.816
Boardman 164
Nyköping 104
Chandler 89
Fairfield 85
Ashburn 65
Singapore 62
Santa Clara 53
Shanghai 47
New York 36
Rome 36
Houston 35
Wilmington 32
Seattle 30
Cambridge 28
Woodbridge 26
Helsinki 22
Los Angeles 22
Amsterdam 21
Pune 20
San Diego 18
Boston 17
Beijing 15
Seoul 14
Guangzhou 12
Shenzhen 12
Munich 11
London 10
Toronto 10
Dong Ket 8
Dublin 7
Paris 7
Wuhan 7
Zhengzhou 6
Hong Kong 5
Jacksonville 5
Menlo Park 5
Sassari 5
Ann Arbor 4
Buffalo 4
Dearborn 4
Hefei 4
La Maddalena 4
Nanjing 4
Naples 4
Romainville 4
Selargius 4
Sestu 4
Vienna 4
Wuxi 4
Belize City 3
Brussels 3
Hangzhou 3
Istanbul 3
Nakano 3
Nuremberg 3
Pamplona 3
Peristeri 3
San Cipriano d'Aversa 3
San Francisco 3
Turin 3
Washington 3
Centro 2
Delhi 2
Don Mueang 2
Enna 2
Godo 2
Islington 2
Jiaxing 2
Jinan 2
Jinhua 2
Lappeenranta 2
Leuven 2
Livorno 2
Milan 2
Molenbeek-Saint-Jean 2
New Bedfont 2
Norwalk 2
Olbia 2
Piacenza 2
Pisa 2
Redwood City 2
Salerno 2
San Giorgio a Cremano 2
Sydney 2
Tokyo 2
Xian 2
Yantai 2
Acton 1
Alexandria 1
Almaty 1
Amgaon 1
Ankara 1
Assèmini 1
Augusta 1
Basel 1
Bergamo 1
Bilbao 1
Borås 1
Totale 32.112
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.132
Molecular-biology-driven treatment for metastatic colorectal cancer 2.613
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.213
New therapeutic targets in pancreatic cancer 1.505
Immunotherapy and Cancer: The Multi-Omics Perspective 1.455
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.402
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.225
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.087
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.044
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 901
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 852
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 847
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 835
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 802
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 792
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 790
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 777
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 716
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 658
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 603
Uncovering key targets of success for immunotherapy in pancreatic cancer 577
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 565
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 561
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 549
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 547
BRCA-mutant pancreatic ductal adenocarcinoma 479
Immune Checkpoint Inhibitors in the Treatment of HCC 471
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 422
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 421
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 384
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 381
Primary adrenal insufficiency induced by immune checkpoint inhibitors: Biological, clinical, and radiological aspects 359
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 317
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 299
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 297
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 229
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects 208
Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas 206
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 162
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 151
A new prognostic score for biliary tract cancer: a multicenter experience 120
Artificial Intelligence Models for the Detection of Microsatellite Instability from Whole-Slide Imaging of Colorectal Cancer 104
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 99
CD44: A New Prognostic Marker in Colorectal Cancer? 89
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 88
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 84
Medical management of malignant bowel obstruction: our center experience 82
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 81
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 68
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 65
Early taxane exposure and neurotoxicity in breast cancer patients 33
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors 13
Totale 32.760
Categoria #
all - tutte 45.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020809 0 0 0 0 254 210 182 35 20 33 23 52
2020/20214.569 78 143 108 1.502 869 530 186 310 140 289 252 162
2021/20222.042 127 87 24 97 119 135 96 187 170 229 334 437
2022/20235.037 400 643 563 372 376 438 226 391 428 528 441 231
2023/20245.556 261 184 185 280 429 859 960 424 371 351 576 676
2024/202514.548 5.035 5.672 1.555 1.659 627 0 0 0 0 0 0 0
Totale 32.760